A Response to: Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination".
作者信息
Albertson Timothy E, Hansen Caitlin, Gayed Juleen, Xu Xia, Feng Ye, Ma Hua
机构信息
UC Davis Medical Center, Sacramento, CA, USA.
Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
出版信息
Infect Dis Ther. 2025 May;14(5):1137-1141. doi: 10.1007/s40121-025-01138-x. Epub 2025 Apr 7.
Abstract
摘要
相似文献
1
A Response to: Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination".对《致编辑的信：关于BNT162b2疫苗接种后5至30岁人群的血清肌钙蛋白I评估》的回复
Infect Dis Ther. 2025 May;14(5):1137-1141. doi: 10.1007/s40121-025-01138-x. Epub 2025 Apr 7.
2
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination.BNT162b2疫苗接种后5至30岁人群的血清肌钙蛋白I评估
Infect Dis Ther. 2024 Apr;13(4):699-714. doi: 10.1007/s40121-024-00927-0. Epub 2024 Mar 15.
3
Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024.致编辑的信：关于阿尔伯森等人于2024年发表的《BNT162b2疫苗接种后5至30岁人群的血清肌钙蛋白I评估》
Infect Dis Ther. 2025 May;14(5):1133-1136. doi: 10.1007/s40121-025-01136-z. Epub 2025 Apr 7.
4
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.BNT162b2 和 mRNA-1273 新冠疫苗接种后的心肌炎和心包炎风险。
Vaccine. 2022 Aug 19;40(35):5153-5159. doi: 10.1016/j.vaccine.2022.07.007. Epub 2022 Jul 12.
5
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.mRNA COVID-19 疫苗接种后的心肌炎和/或心包炎风险：BNT162b2 和 mRNA-1273 疫苗的加拿大头对头比较。
Vaccine. 2022 Jul 30;40(32):4663-4671. doi: 10.1016/j.vaccine.2022.05.048. Epub 2022 May 25.
6
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.泰国新冠疫苗接种后的心肌炎和心包炎
Vaccines (Basel). 2023 Mar 28;11(4):749. doi: 10.3390/vaccines11040749.
7
Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines.接种Ad26.COV2.S、BNT162b2 mRNA或mRNA-1273新冠病毒疫苗个体的心肌炎和心包炎
Front Cardiovasc Med. 2023 Nov 24;10:1210007. doi: 10.3389/fcvm.2023.1210007. eCollection 2023.
8
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.意大利 12 至 39 岁人群接种 COVID-19 mRNA 疫苗后的心肌炎和心包炎上市后主动监测：多数据库、自身对照病例系列研究。
PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul.
9
10
Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.加拿大安大略省 12 至 17 岁人群接种 BNT162b2 疫苗后的心肌炎或心包炎事件。
JAMA Pediatr. 2023 Apr 1;177(4):410-418. doi: 10.1001/jamapediatrics.2022.6166.
本文引用的文献
1
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination.BNT162b2疫苗接种后5至30岁人群的血清肌钙蛋白I评估
Infect Dis Ther. 2024 Apr;13(4):699-714. doi: 10.1007/s40121-024-00927-0. Epub 2024 Mar 15.
2
Simple improved confidence intervals for comparing matched proportions.用于比较匹配比例的简单改进置信区间。
Stat Med. 2005 Mar 15;24(5):729-40. doi: 10.1002/sim.1781.
Zotero 插件